文献速递艾滋病与性传播感染

定量HIV-1抗体与接受抗逆转录病毒治疗儿童血浆HIV-1 RNA及细胞相关DNA水平的相关性

Quantitative Human Immunodeficiency Virus (HIV)-1 Antibodies Correlate With Plasma HIV-1 RNA and Cell-associated DNA Levels in Children on Antiretroviral Therapy.
PubMed 文献 · Clin Infect Dis · 2019-01-01

本研究对46名2岁前启动ART的HIV-1感染儿童(按启动年龄分早期治疗ET与晚期治疗LT,按病毒学应答分应答R与无应答NR)及20名HIV-1暴露未感染儿童(血清逆转者SR)对照,连续定量检测血浆HIV-1特异性IgG抗体水平。结果显示ET-R组多数抗体下降速率与SR组相似,而LT-R和NR组下降显著更慢;1岁后p31和p17抗体水平与HIV-1 RNA显著相关,gp160和gp41抗体水平与细胞相关HIV-1 DNA显著相关。定量HIV-1特异性抗体或可用于筛查ART儿童的病毒抑制或残留细胞相关DNA水平。

要点

  • 早期治疗且病毒学应答儿童的HIV-1抗体下降速率与血清逆转者相似(除p17外)。
  • 晚期治疗应答者和无应答者所有检测抗体下降速率均显著慢于血清逆转者。
  • 1岁后p31/p17抗体与HIV-1 RNA相关,gp160/gp41抗体与细胞相关DNA相关。

核心结论

  • 定量HIV-1特异性抗体水平可能有助于筛查接受ART儿童的病毒抑制或残留细胞相关HIV-1 DNA水平。

研究设计与样本

  • 研究纳入46名HIV-1感染儿童,按ART启动年龄(<3月为ET,>3月-2年为LT)和病毒学应答(R/NR)分层,另设20名HIV-1暴露未感染血清逆转者(SR)对照。
  • 采用定量酶联免疫吸附试验连续检测针对gp160、gp41、p24、p17、p66/51和p31的血清IgG抗体水平,并估算研究前15个月的抗体下降速率。

主要发现

  • ET-R组所有抗体特异性下降速率与SR组相似,但p17例外(P = .01)。
  • LT-R组和NR组所有检测抗体特异性下降速率均显著慢于SR组。
  • 1岁后,p31和p17抗体水平与HIV-1 RNA水平显著相关(P < .001)。
  • 1岁后,gp160(P < .001)和gp41(P < .001)抗体水平与细胞相关HIV-1 DNA水平显著相关。

临床怎么用

  • 在资源有限或无法常规检测HIV-1 RNA/DNA的场景下,可考虑用定量HIV-1特异性抗体辅助筛查ART儿童的病毒抑制状态或残留细胞相关DNA。
  • 对1岁后儿童,p31/p17抗体可提示HIV-1 RNA水平,gp160/gp41抗体可提示细胞相关HIV-1 DNA水平。

局限性

  • 样本量较小(46名感染儿童和20名对照),结果需更大队列验证。
  • 抗体下降速率仅估算研究前15个月,长期动态未充分描述。
  • 研究未报告抗体检测的敏感度、特异度或临床阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study measured serial plasma human immunodeficiency virus (HIV)-1-specific antibody (Ab) levels in children who initiated antiretroviral therapy (ART) prior to 2 years of age, and evaluated their relationship to peripheral blood HIV-1 RNA and DNA levels. METHODS: We studied 46 HIV-1-infected children, stratified by age at ART initiation (<3 mo, early therapy [ET]; >3 mo-2 years, late therapy [LT]) and by virologic response (R) or non-response (NR), before and up to 4 years following ART. We studied 20 HIV-1-uninfected children born to HIV-1-infected mothers (seroreverters [SR]) as controls. Plasma immunoglobulin G (IgG) Ab levels directed against HIV-1 envelope (gp160, gp41), gag (capsid, p24; matrix, p17), reverse transcriptase (p66/51), and integrase (p31) were serially measured using quantitative enzyme-linked immunosorbent assays. HIV-1 Ab rates of decline were estimated over the first 15 months of the study. RESULTS: The HIV-1 Ab rates of decline in the ET-R group were similar to those in the SR group for all Ab specificities, except for p17 (P = .01). Ab decline rates in the LT-R group and the NR group were significantly slower than in the SR group for all tested Ab specificities. After 1 year of age, Ab levels to p31 and p17 were significantly associated with HIV-1 RNA levels (P < .001); Ab levels to gp160 (P < .001) and gp41 (P < .001) were significantly associated with cell-associated HIV-1 DNA levels. CONCLUSIONS: Quantitative HIV-1-specific Ab levels may be useful for screening children on ART for viral suppression or for residual, cell-associated HIV-1 DNA levels. CLINICAL TRIALS REGISTRATION: NCT00000872.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. McManus M, Henderson J, Gautam A, et al. Quantitative Human Immunodeficiency Virus (HIV)-1 Antibodies Correlate With Plasma HIV-1 RNA and Cell-associated DNA Levels in Children on Antiretroviral Therapy. Clin Infect Dis. 2019. PMID: 30668843. doi:10.1093/cid/ciy753

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。